These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27339779)

  • 1. Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial.
    Cicero AF; Colletti A; Fogacci F; Bove M; Rosticci M; Borghi C
    High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):13-18. PubMed ID: 27339779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial.
    Trimarco V; Izzo R; Stabile E; Rozza F; Santoro M; Manzi MV; Serino F; Schiattarella GG; Esposito G; Trimarco B
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):149-54. PubMed ID: 25870124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis.
    Trimarco V; Battistoni A; Tocci G; Coluccia R; Manzi MV; Izzo R; Volpe M
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):850-857. PubMed ID: 28965797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product.
    Cicero AFG; Fogacci F; Morbini M; Colletti A; Bove M; Veronesi M; Giovannini M; Borghi C
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):283-288. PubMed ID: 28537012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials.
    Pirro M; Mannarino MR; Bianconi V; Simental-Mendía LE; Bagaglia F; Mannarino E; Sahebkar A
    Pharmacol Res; 2016 Aug; 110():76-88. PubMed ID: 27157250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.
    Cicero AF; Derosa G; Parini A; Maffioli P; D'Addato S; Reggi A; Giovannini M; Borghi C
    Nutr Res; 2013 Aug; 33(8):622-8. PubMed ID: 23890351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effects of a New Generation of Nutraceutical Compounds on Lipid Profile and Glycaemia in Subjects with Pre-hypertension.
    Mazza A; Schiavon L; Rigatelli G; Torin G; Lenti S
    High Blood Press Cardiovasc Prev; 2019 Aug; 26(4):345-350. PubMed ID: 31352663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study.
    Ruscica M; Pavanello C; Gandini S; Macchi C; Botta M; Dall'Orto D; Del Puppo M; Bertolotti M; Bosisio R; Mombelli G; Sirtori CR; Calabresi L; Magni P
    Nutr J; 2019 Feb; 18(1):13. PubMed ID: 30795775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized, Double-Blinded, Placebo-Controlled, Clinical Study of the Effects of a Nutraceutical Combination (LEVELIP DUO
    Cicero AFG; D'Addato S; Borghi C
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33066334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of a combined lipid-lowering nutraceutical on cholesterolemia, hs-CRP level and endothelial function in moderately hypercholesterolemic subjects.
    Cicero AF; Colletti A; Rosticci M; Grandi E; Borghi C
    J Biol Regul Homeost Agents; 2016; 30(2):593-8. PubMed ID: 27358154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferulic Acid Supplementation Improves Lipid Profiles, Oxidative Stress, and Inflammatory Status in Hyperlipidemic Subjects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Bumrungpert A; Lilitchan S; Tuntipopipat S; Tirawanchai N; Komindr S
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29865227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Safety of Dietetic Supplementation of a New Nutraceutical on Lipid Profile and Serum Inflammation Biomarkers in Hypercholesterolemic Patients.
    Riccioni G; Gammone MA; Currenti W; D'Orazio N
    Molecules; 2018 May; 23(5):. PubMed ID: 29757945
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of a Novel Nutraceutical Combination (Aquilea Colesterol
    Domenech M; Casas R; Ruiz-León AM; Sobrino J; Ros E; Estruch R
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
    Marazzi G; Cacciotti L; Pelliccia F; Iaia L; Volterrani M; Caminiti G; Sposato B; Massaro R; Grieco F; Rosano G
    Adv Ther; 2011 Dec; 28(12):1105-13. PubMed ID: 22113535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, Double-Blind, Placebo-Controlled Trial to Test the Effects of a Nutraceutical Combination Monacolin K-Free on the Lipid and Inflammatory Profile of Subjects with Hypercholesterolemia.
    Protic O; Di Pillo R; Montesanto A; Galeazzi R; Matacchione G; Giuliani A; Sabbatinelli J; Gurău F; Silvestrini A; Olivieri F; Antonicelli R; Bonfigli AR
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
    Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
    J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q
    D'Addato S; Scandiani L; Mombelli G; Focanti F; Pelacchi F; Salvatori E; Di Loreto G; Comandini A; Maffioli P; Derosa G
    Drug Des Devel Ther; 2017; 11():1585-1592. PubMed ID: 28579756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a novel nutraceutical combination (BruMeChol™) in subjects with mild hypercholesterolemia: study protocol of a randomized, double-blind, controlled trial.
    Bonfigli AR; Protic O; Olivieri F; Montesanto A; Malatesta G; Di Pillo R; Antonicelli R
    Trials; 2020 Jul; 21(1):616. PubMed ID: 32631422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects.
    Cicero AF; Morbini M; Parini A; Urso R; Rosticci M; Grandi E; Borghi C
    Ther Clin Risk Manag; 2016; 12():281-6. PubMed ID: 26966368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.
    Cicero AFG; Fogacci F; Bove M; Veronesi M; Rizzo M; Giovannini M; Borghi C
    Adv Ther; 2017 Aug; 34(8):1966-1975. PubMed ID: 28687937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.